Skip to content

Influence of training with intelligent walking aid under suspension protection on patients with early stroke

Influence of training with intelligent walking aid under suspension protection on patients with early stroke

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070247
Enrollment
Unknown
Registered
2023-04-06
Start date
2023-04-13
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral stroke

Interventions

experimental group:Wear a smart walker for training
Control group:Training without wearing a smart walker

Sponsors

Shenzhen University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Cerebral hemorrhage or cerebral infarction patients aged 18-70 years who met the diagnostic criteria of stroke in the Fourth National Cerebrovascular Conference and were diagnosed as single lesion by CT or MRI; 2. The patient has clear consciousness, no severe cognitive and sensory disorders, no sensory aphasia, and can understand and follow simple motor instructions; 3. The first stroke was in the early stage (<= 3 months after ischemic or hemorrhagic attack), only involved unilateral limbs, the condition was stable, no postural hypotension and other complications; 4. Perfect medical records and related data; Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Multiple strokes involving limb function; 2. Complicated with other mental diseases and severe nervous system diseases, hemiplegia or related symptoms caused by other diseases, other neuromuscular or skeletal diseases; 3. Complicated with other serious heart, lung, renal insufficiency, serious liver function and malignant tumor; 4. Cognitive impairment, obvious aphasia, inability to understand instructions, and inability to accurately express discomfort during the test; 5. Severe spasms restrict lower limb movement (Ashworth > 3); 6. Patients or their family members refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Brunnstrom staging;Modified ashworth scale;

Secondary

MeasureTime frame
Fugl-Meyer (lower extremity);Berg balance scale;

Countries

China

Contacts

Public ContactShanxin Ma

Shenzhen University General Hospital

583948337@qq.com+86 136 5243 5176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026